Monitoring parameters typically assessed in trials include: Body weight and BMI measured at each visit to track progress Blood glucose and HbA1c particularly important for participants with type 2 diabetes or non-diabetic hyperglycaemia (sometimes called prediabetes) Lipid profile including total cholesterol, LDL, HDL, and triglycerides Liver function tests given the metabolic effects of glucagon receptor activation Renal function especially relevant if gastrointestinal side effects lead to reduced fluid intake Blood pressure and heart rate cardiovascular parameters are routinely assessed Calcitonin levels some trial protocols include calcitonin measurement given the theoretical thyroid C-cell risk associated with GLP-1 receptor agonists, based on rodent data
Es cierto que podemos encontrar productos en el mercado con dosificaciones superiors, pero esto no quiere decir que su eficacia vaya a ser mayor
Use low heat when cooking asparagus, onions or garlic
Many challenges are ahead of us as are many opportunities, Kautzner said
"No pain, no gain" loses its motivating ability when it tends to be all pain and very little gain, for weeks on end, doesn't it
Genome-wide association studies have identified more than 260 single-nucleotide polymorphisms linked to AF pathogenesis, and genetic risk scores may enhance the accuracy of AF risk stratification (51, 52)
